Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vertex Pharmaceuticals
Fierce Pharma
Vertex to pay $10B for Crinetics in its largest-ever deal
Vertex has scored its largest-ever transaction, agreeing to acquire Crinetics and two of its drugs that have combined peak sales potential of $5B.
Kevin Dunleavy
Jul 7, 2026 8:08am
Vertex drops Moderna-partnered inhaled CF candidate
May 4, 2026 5:48pm
AbbVie inks $745M deal with China’s Haisco for two pain assets
Apr 13, 2026 9:48am
Maze stock plummets after potential 'best-in-class' ph. 2 data
Mar 25, 2026 10:57am
Vertex races to FDA after phase 3 kidney disease data impress
Mar 10, 2026 6:20am
Sarepta CEO to step down as DM1 hits home—Chutes & Ladders
Feb 27, 2026 8:30am
